This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Barbara Burton: Innovator in Genetic Research
Introduction
Barbara Burton is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of genetic research, particularly in understanding lysosomal acid lipase deficiency. Her work has implications for the treatment of genetic disorders, showcasing her dedication to advancing medical science.
Latest Patents
Barbara Burton holds a patent for "Lysosomal acid lipase deficiency compositions and methods." This patent focuses on compositions and methods relating to potentially pathogenic mutations in the nucleotide sequence of the human LIPA gene. Some LIPA gene products have been discovered to be associated with reduced lysosomal acid lipase (LAL) activity. This innovation is crucial for developing therapies for conditions related to LAL deficiency.
Career Highlights
Barbara is currently employed at Alexion Pharmaceuticals, Inc., where she continues her research and development efforts. Her work at Alexion has allowed her to collaborate with leading experts in the field, further enhancing her contributions to genetic research.
Collaborations
Some of her notable coworkers include Andrew Hutchinson and John V W Reynders. Their collaboration has fostered an environment of innovation and discovery, leading to advancements in understanding lysosomal disorders.
Conclusion
Barbara Burton's work exemplifies the impact of innovative research in genetics. Her patent and ongoing contributions to the field highlight her role as a key figure in advancing medical science. Her dedication to improving patient outcomes through research is commendable and inspiring.